{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:36:00Z","timestamp":1776472560478,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.medcli.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T22:47:44Z","timestamp":1676069264000},"page":"305-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vacunas frente a la viruela del mono (monkeypox)"],"prefix":"10.1016","volume":"160","author":[{"given":"Jordi","family":"Reina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2023.01.001_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000416456","article-title":"Human monkeypox","volume":"17","author":"Jezek","year":"1988","journal-title":"Monogr Virol"},{"key":"10.1016\/j.medcli.2023.01.001_bib0180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2023.01.001_bib0185","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.medcli.2023.01.001_bib0190","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.medcli.2018.03.025","article-title":"\u00bfDeber\u00edamos empezar a preocuparnos por la viruela del mono?","volume":"151","author":"Reina","year":"2018","journal-title":"Med Clin (Barc.)"},{"key":"10.1016\/j.medcli.2023.01.001_bib0195","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western Hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2023.01.001_bib0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/fvl.12.130","article-title":"A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012","volume":"8","author":"Parker","year":"2013","journal-title":"Future Virol"},{"issue":"S4","key":"10.1016\/j.medcli.2023.01.001_bib0205","doi-asserted-by":"crossref","first-page":"D54","DOI":"10.1016\/j.vaccine.2011.04.014","article-title":"Status of human monkeypox: clinical disease, epidemiology and research","volume":"29","author":"Damon","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.medcli.2023.01.001_bib0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medcli.2023.01.001_bib0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(86)90748-8","article-title":"Isolation of monkeypox virus from wild squirrel infected in nature","volume":"1","author":"Khodakevich","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2023.01.001_bib0220","first-page":"1","article-title":"Monkeypox: disease epidemiology, host immunity and cliniocal interventions","volume":"5","author":"Lum","year":"2022","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.medcli.2023.01.001_bib0225","unstructured":"World Health Organizarion (2022). Monkeypox. Disponible en: https:\/\/www.who.int\/health-topics\/monkeypox."},{"key":"10.1016\/j.medcli.2023.01.001_bib0230","unstructured":"World Health Organization, Vaccines and immunization for monkeypox: Interim guidance. 24 August 2022. [consultado 13 Sep 2022]. Disponible en: https:\/\/www.who.int\/publications\/i\/item\/WHO-MPX-Immunization-2022.2-eng."},{"key":"10.1016\/j.medcli.2023.01.001_bib0235","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMp2210125","article-title":"Tecovirimat and the treatment of monkeypox: past, present and future considerations","volume":"387","author":"Sherwat","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2023.01.001_bib0240","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/vaccines6010008","article-title":"Challenges and achievements in prevention and treatment of smallpox","volume":"6","author":"Melamed","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.medcli.2023.01.001_bib0245","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/clinids\/4.5.916","article-title":"A successful eradication campaign. Global eradication of smallpox","volume":"4","author":"Fenner","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.medcli.2023.01.001_bib0250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1017\/S002217240000053X","article-title":"The development of a stable smallpox vaccine","volume":"53","author":"Collier","year":"1955","journal-title":"J Hyg"},{"key":"10.1016\/j.medcli.2023.01.001_bib0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000TM. The new smallpox vaccine for United States strategic national stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.medcli.2023.01.001_bib0260","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ijid.2004.09.002","article-title":"ACAM2000 clonal Vero cell culture vaccinia virus (New York City board of health strain), a second generation smallpox vaccine for viological defense","volume":"S2","author":"Monath","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.medcli.2023.01.001_bib0265","article-title":"Prevention and treatment of monkeypox","author":"Rizk","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.medcli.2023.01.001_bib0270","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/14760584.2016.1175305","article-title":"Defending against smallpox: a focus on vaccines","volume":"15","author":"Voigt","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.medcli.2023.01.001_bib0275","unstructured":"ACAM2000 Package insert. Gaitherburg, MD: emergent product development Gaithersburg Inc 2007. [consultado Sep 2022]. Disponible en: https:\/\/www.fda.gov\/media\/75792\/dowload.."},{"key":"10.1016\/j.medcli.2023.01.001_bib0280","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1126\/science.add3743","article-title":"Monkeypox vaccination plans take shape amid questions","volume":"376","author":"Kupferschmidt","year":"2022","journal-title":"Science."},{"key":"10.1016\/j.medcli.2023.01.001_bib0285","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","article-title":"Phase 3 efficacy trial of modified vaccinia Ankara as a vaccineagainst smallpox","volume":"381","author":"Pittman","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2023.01.001_bib0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157335","article-title":"A randomized, double-blind, placebo-controled phase II trial investigating the safety and immunogenicity of modified vaccinia Ankara smallpox vaccine (MVA-BN) in 56-80-year-old subjects","author":"Greenberg","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.medcli.2023.01.001_bib0295","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.medcli.2023.01.001_bib0300","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/infdis\/jiab111","article-title":"Human antibody responses following vaccinia immunization using protein microarrays and correlation with cell-mediated immunity and antibody-depeddnt celular cytotoxicity responses","volume":"224","author":"Frey","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medcli.2023.01.001_bib0305","first-page":"819","article-title":"FDA authorizes intradermal vaccine, streamlines rules to increase monkeypox treatment Access","volume":"328","author":"Larkin","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2023.01.001_bib0310","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMp2211311","article-title":"Intradermal Vaccination for Monkeypox - Benefits for Individual and Public Health","volume":"387","author":"Brooks","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2023.01.001_bib0315","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and immunigenicity of LC16m8, an attenuted smallpox vaccine in vaccinia-naive adults","volume":"204","author":"Kennedy","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medcli.2023.01.001_bib0320","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1016\/j.vaccine.2015.07.111","article-title":"Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8","volume":"33","author":"Eto","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.medcli.2023.01.001_bib0325","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1099\/vir.0.2008\/004440-0","article-title":"Vaccinia virus strain nyvac induces substantially lower and qualitatively different human antibody responses compared with strains lister and dryvax","volume":"89","author":"Midgley","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.medcli.2023.01.001_bib0330","unstructured":"Ponencia de alertas y planes de preparaci\u00f3n y respuesta. Protocolo para la detecci\u00f3n precoz y manejo de casos ante la alerta de viruela de los monos (monkeypox) en Espa\u00f1a. Ministerio de Sanidad. [consultado 5 Ago 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/alertaMonkeypox\/home.htm."},{"key":"10.1016\/j.medcli.2023.01.001_bib0335","unstructured":"Comisi\u00f3n de Salud P\u00fablica. Recomendaciones de vacunaci\u00f3n en el brote actual de viruela del mono. Consejo interterritorial. Ministerio de Sanidad. [consultado 9 Jun 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/MonkeyPox\/docs\/Propuesta_vacunacion_Monkeypox.pdf."},{"key":"10.1016\/j.medcli.2023.01.001_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00574-6","article-title":"Prevention of monkeypox with vaccines: a rapid review","author":"Poland","year":"2022","journal-title":"Lancet Infect Dis."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T01:08:39Z","timestamp":1679360919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775323000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0025775323000027"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2023.01.001","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vacunas frente a la viruela del mono (monkeypox)","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}